Overview of ER+ Breast Cancer Estrogen receptor-positive (ER+) breast cancer accounts for nearly 70% of all breast cancer cases. This subtype relies on estrogen for tumor growth, making hormone therapy a key treatment approach. Targeted therapies have significantly improved patient outcomes by focusing on disrupting estrogen signaling pathways to slow disease progression. Current Treatments for...